Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.89 EUR | -2.07% | -2.83% | -5.50% |
Mar. 25 | Facephi Biometria, S.A. announced that it expects to receive funding from Hancom Inc. | CI |
2023 | Facephi Biometria, S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
Capitalization 1 | 9.863 | 40.98 | 73.01 | 59.24 | 41.09 |
Enterprise Value (EV) 1 | 9.863 | 43.66 | 73.55 | 59.24 | 41.94 |
P/E ratio | - | 31.2 x | -43.6 x | - | 27 x |
Yield | - | - | - | - | - |
Capitalization / Revenue | 2.2 x | 5 x | 10 x | 4.5 x | 1.88 x |
EV / Revenue | 2.2 x | 5.33 x | 10.1 x | 4.5 x | 1.88 x |
EV / EBITDA | - | 17.3 x | 81.4 x | - | 49.9 x |
EV / FCF | - | -218 x | 44.9 x | - | -14.5 x |
FCF Yield | - | -0.46% | 2.23% | - | -6.91% |
Price to Book | - | - | - | - | - |
Nbr of stocks (in thousands) | 13,150 | 13,135 | 14,371 | 15,074 | 21,739 |
Reference price 2 | 0.7500 | 3.120 | 5.080 | 3.930 | 1.890 |
Announcement Date | 4/29/19 | 1/20/20 | 2/2/21 | 4/29/22 | 5/1/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
Net sales 1 | 4.481 | 8.195 | 7.266 | 13.16 | 22.28 |
EBITDA 1 | - | 2.517 | 0.9038 | - | 0.9 |
EBIT 1 | - | 2.034 | 0.226 | - | 1.9 |
Operating Margin | - | 24.82% | 3.11% | - | 9.45% |
Earnings before Tax (EBT) 1 | - | 1.718 | -1.83 | - | 1.6 |
Net income 1 | - | 1.288 | -1.682 | -0.5539 | 1.107 |
Net margin | - | 15.72% | -23.15% | -4.21% | 4.97% |
EPS 2 | - | 0.1000 | -0.1166 | - | 0.0700 |
Free Cash Flow 1 | - | -0.2002 | 1.638 | - | -3.1 |
FCF margin | - | -2.44% | 22.54% | - | -15.42% |
FCF Conversion (EBITDA) | - | - | 181.23% | - | - |
FCF Conversion (Net income) | - | - | - | - | - |
Dividend per Share | - | - | - | - | - |
Announcement Date | 4/29/19 | 1/20/20 | 2/2/21 | 4/29/22 | 5/1/23 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
Net Debt 1 | - | 2.68 | 0.55 | - | 3.8 |
Net Cash position 1 | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | 1.064 x | 0.6071 x | - | 4.222 x |
Free Cash Flow 1 | - | -0.2 | 1.64 | - | -3.1 |
ROE (net income / shareholders' equity) | - | 37% | -29.3% | - | 10.3% |
ROA (Net income/ Total Assets) | - | - | - | - | - |
Assets 1 | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - |
Capex 1 | - | - | 0.16 | - | 0.6 |
Capex / Sales | - | - | 2.25% | - | 2.99% |
Announcement Date | 4/29/19 | 1/20/20 | 2/2/21 | 4/29/22 | 5/1/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.50% | 43.86M | |
-25.52% | 1.55B | |
+186.73% | 161M | |
+14.63% | 120M | |
-44.01% | 53.47M |
- Stock Market
- Equities
- FACE Stock
- Financials FacePhi Biometría, S.A.